Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation

por Lu, Genmin, Lin, Joyce, Bui, Khanh, Curnutte, John T., Conley, Pamela B.
Publicado 2020

Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa

por Bourdin, Matthieu, Perrotin, Delphine, Mathieu, Olivier, Herve, Tristan, Depasse, François, Lu, Genmin, Conley, Pamela B., Contant, Geneviève
Publicado 2021

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model

por Lu, Genmin, Pine, Polly, Leeds, Janet M., DeGuzman, Francis, Pratikhya, Pratikhya, Lin, Joyce, Malinowski, John, Hollenbach, Stanley J., Curnutte, John T., Conley, Pamela B.
Publicado 2018

Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs

por Stephens, Gillian, He, Ming, Wong, Connie, Jurek, Marzena, Luedemann, Hans-Christian, Shapurian, Golnaz, Munnelly, Kevin, Muir, Craig, Conley, Pamela B, Phillips, David R, Andre, Patrick
Publicado 2012

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

por Demchuk, Andrew M., Yue, Patrick, Zotova, Elena, Nakamya, Juliet, Xu, Lizhen, Milling, Truman J., Ohara, Tomoyuki, Goldstein, Joshua N., Middeldorp, Saskia, Verhamme, Peter, Lopez-Sendon, Jose Luis, Conley, Pamela B., Curnutte, John T., Eikelboom, John W., Crowther, Mark, Connolly, Stuart J.
Publicado 2021